Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.595 SEK | -0.14% | -5.02% | +16.34% |
05-21 | OncoZenge AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-08 | Oncozenge AB Appoints Paolo Bossi as Member of the Advisory Board | CI |
End-of-day quotes
Sector Other Pharmaceuticals
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
3.94M | - | - | - | - | - | |
723B | ||||||
598B | ||||||
364B | ||||||
331B | ||||||
288B |
- Stock Market
- Equities
- ONCOZ Stock
- Charts OncoZenge AB
- Sector Chart